PROSPECTUS SUPPLEMENT
(To Prospectus Dated February 26, 2021)
Up to $900,000,000

COMMON STOCK
We entered into an equity distribution agreement on November 6, 2020 with Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, BMO Capital Markets Corp., BTIG, LLC, Capital One Securities, Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Evercore Group L.L.C., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Jefferies LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, Raymond James & Associates, Inc., Regions Securities LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, each a “sales agent” and collectively the “sales agents,” pursuant to which we may offer and sell over a period of time and from time to time through the sales agents up to $900,000,000 aggregate offering price of shares of our common stock offered by this prospectus supplement and the accompanying prospectus. Of that amount, we have sold shares of our common stock having an aggregate offering price of $113,015,095 as of the date of this prospectus supplement, pursuant to a Registration Statement on Form S-3 (File No. 333-223206) filed on February 23, 2018 and a prospectus supplement dated November 6, 2020. Accordingly, as of the date of this prospectus supplement, shares of common stock having an aggregate offering price of up to $786,984,905 remain available for offer and sale pursuant to this prospectus supplement and the accompanying prospectus.
Sales of common stock pursuant to this prospectus supplement and the accompanying prospectus, if any, may be made in negotiated transactions or transactions that are deemed to be “at-the-market” transactions as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), including sales made by means of ordinary brokers’ transactions through the facilities of the New York Stock Exchange (the “NYSE”) at market prices, in block transactions, to or through a market maker, through an electronic communications network, or as otherwise agreed between the applicable sales agent and us. None of the sales agents is required to sell any specific dollar amount of shares, but each will, subject to the terms and conditions of the equity distribution agreement, use its commercially reasonable efforts to sell the shares offered as instructed by us.
Under the terms of the equity distribution agreement, we also may sell shares of common stock to a sales agent as principal for its own account at a price agreed upon at the time of the sale. If we sell shares of common stock to any sales agent as principal, then we will enter into a separate terms agreement with that sales agent, and we will describe that terms agreement in a separate prospectus supplement or pricing supplement.
Each sales agent will receive from us a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of all shares sold through it as sales agent under the equity distribution agreement. For more information, see “Plan of Distribution” in this prospectus supplement.
Our common stock is listed on the NYSE under the symbol “STOR.” On February 25, 2021, the last sale price of our common stock as reported on the NYSE was $33.86 per share.
We have elected to qualify as a real estate investment trust for U.S. federal income tax purposes (“REIT”). Our charter contains certain restrictions relating to the ownership and transfer of our common stock to assist us, among other purposes, in maintaining our qualification as a REIT, including, subject to certain exceptions, a 9.8% limit, in value or by number of shares, whichever is more restrictive, on the ownership of outstanding shares of our common stock and a 9.8% limit, in value, on the ownership of shares of all classes and series of our outstanding stock. See “Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our common stock involves risks. You should carefully read and consider the information in the section entitled “Risk Factors” included in our in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as may be updated by our subsequent filings under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and on page S-2 of this prospectus supplement.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | |
Baird | | Berenberg | | BMO Capital Markets |
BTIG | | Capital One Securities | | Citigroup |
Credit Suisse | | Evercore ISI | | Goldman Sachs & Co. LLC |
J.P. Morgan | | Jefferies | | KeyBanc Capital Markets |
Morgan Stanley | | Raymond James | | Regions Securities LLC |
Truist Securities | | Wells Fargo Securities | | |
The date of this prospectus supplement is February 26, 2021